JP2017525697A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525697A5
JP2017525697A5 JP2017507903A JP2017507903A JP2017525697A5 JP 2017525697 A5 JP2017525697 A5 JP 2017525697A5 JP 2017507903 A JP2017507903 A JP 2017507903A JP 2017507903 A JP2017507903 A JP 2017507903A JP 2017525697 A5 JP2017525697 A5 JP 2017525697A5
Authority
JP
Japan
Prior art keywords
fluoro
methoxy
chloro
fluorophenyl
hydroxypiperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017507903A
Other languages
English (en)
Japanese (ja)
Other versions
JP6625612B2 (ja
JP2017525697A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2015/004371 external-priority patent/WO2016031255A1/en
Publication of JP2017525697A publication Critical patent/JP2017525697A/ja
Publication of JP2017525697A5 publication Critical patent/JP2017525697A5/ja
Application granted granted Critical
Publication of JP6625612B2 publication Critical patent/JP6625612B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017507903A 2014-08-28 2015-08-28 二環式複素環化合物及びその結核治療用途 Active JP6625612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014174528 2014-08-28
JP2014174528 2014-08-28
PCT/JP2015/004371 WO2016031255A1 (en) 2014-08-28 2015-08-28 Heterobicyclic compounds and their use for the treatment of tuberculosis

Publications (3)

Publication Number Publication Date
JP2017525697A JP2017525697A (ja) 2017-09-07
JP2017525697A5 true JP2017525697A5 (enExample) 2018-12-06
JP6625612B2 JP6625612B2 (ja) 2019-12-25

Family

ID=54105947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017507903A Active JP6625612B2 (ja) 2014-08-28 2015-08-28 二環式複素環化合物及びその結核治療用途

Country Status (29)

Country Link
US (2) US10053446B2 (enExample)
EP (1) EP3186240B9 (enExample)
JP (1) JP6625612B2 (enExample)
KR (1) KR102418413B1 (enExample)
CN (1) CN106795117B (enExample)
AP (1) AP2017009788A0 (enExample)
AR (1) AR101704A1 (enExample)
AU (1) AU2015307873B2 (enExample)
BR (1) BR112017003231B1 (enExample)
CA (1) CA2959478C (enExample)
CY (1) CY1122286T1 (enExample)
DK (1) DK3186240T3 (enExample)
EA (1) EA038414B1 (enExample)
ES (1) ES2743788T3 (enExample)
HR (1) HRP20191486T2 (enExample)
HU (1) HUE045025T2 (enExample)
IL (1) IL250484B (enExample)
LT (1) LT3186240T (enExample)
MX (1) MX2017002312A (enExample)
MY (1) MY189098A (enExample)
NZ (1) NZ729064A (enExample)
PH (1) PH12017500290B1 (enExample)
PL (1) PL3186240T3 (enExample)
PT (1) PT3186240T (enExample)
SG (1) SG11201700882XA (enExample)
SI (1) SI3186240T1 (enExample)
TW (1) TWI687409B (enExample)
WO (1) WO2016031255A1 (enExample)
ZA (1) ZA201700916B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI687409B (zh) * 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
CN108884044B (zh) * 2016-02-26 2023-01-31 大塚制药株式会社 哌啶衍生物
CN112543757A (zh) 2018-06-15 2021-03-23 卡迪拉保健有限公司 对结核菌具有抗菌活性的缩合氮杂杂芳基化合物
JP2023085582A (ja) * 2020-05-11 2023-06-21 大塚製薬株式会社 ジヒドロキノリノン化合物の共結晶
WO2022039506A1 (ko) * 2020-08-19 2022-02-24 주식회사 미토이뮨테라퓨틱스 Mabc-r 감염에 의한 병적 염증 치료제로서의 미토콘드리아 표적 항산화제
CN116102537B (zh) * 2021-11-10 2024-10-01 四川大学 一种喹啉酮类衍生物及其制备方法和用途
CN116589448B (zh) * 2023-04-24 2025-10-28 西南交通大学 一种3,4-二氢喹啉酮衍生物及其应用
WO2025183016A1 (ja) * 2024-02-26 2025-09-04 大塚製薬株式会社 Quabodepistat含有組成物
WO2025183017A1 (ja) * 2024-02-26 2025-09-04 大塚製薬株式会社 Quabodepistat含有組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
AR041198A1 (es) 2002-10-11 2005-05-04 Otsuka Pharma Co Ltd Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
GB0319150D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
CN100497345C (zh) * 2003-10-31 2009-06-10 大塚制药株式会社 治疗结核病的2,3-二氢-6-硝基咪唑并[2,1-b]唑化合物
PL1678185T3 (pl) 2003-10-31 2009-04-30 Otsuka Pharma Co Ltd Związki 2,3-dihydro-6-nitroimidazo[2,1-B]oksazolu do leczenia gruźlicy
JP4761756B2 (ja) 2003-10-31 2011-08-31 大塚製薬株式会社 2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物
PL2502911T3 (pl) * 2004-06-24 2017-09-29 Vertex Pharma Modulatory transporterów kasety wiążącej ATP
JPWO2007099828A1 (ja) 2006-02-23 2009-07-16 塩野義製薬株式会社 環式基で置換された含窒素複素環誘導体
GB0812648D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
WO2010045987A1 (en) * 2008-10-23 2010-04-29 Glaxo Group Limited Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
ES2530266T3 (es) 2009-07-31 2015-02-27 Global Alliance For Tb Drug Development Análogos de nitroimidazooxazina y sus usos
EP2697232B1 (en) 2011-04-15 2016-05-18 Otsuka Pharmaceutical Co., Ltd. 6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides
TWI687409B (zh) * 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
CN108884044B (zh) * 2016-02-26 2023-01-31 大塚制药株式会社 哌啶衍生物

Similar Documents

Publication Publication Date Title
JP2017525697A5 (enExample)
ES2441765T3 (es) Compuestos neuroterapéuticos de azol
RU2439068C2 (ru) Модуляторы mglur5
RU2436785C2 (ru) Гетеробициклические карбоксамиды в качестве ингибиторов киназ
JP2006528939A5 (enExample)
JP5485391B2 (ja) P2x7調節薬としてのジヒドロピリミドンアミド類
US20100190783A1 (en) Triazolone derivatives
EP2280945A1 (en) Trisubstituted pyrazoles as acetylcholine receptor modulators
JP2004522792A5 (enExample)
KR20130082183A (ko) 이소인돌론 화합물 및 대사성 글루타메이트 수용체 증강제로서 이들의 용도
JP2007519695A5 (enExample)
JP5587246B2 (ja) レニン阻害剤としての3,4−置換ピペリジン誘導体
WO1998050358A1 (en) Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
RU2485107C2 (ru) Антималярийные соединения с гибкими боковыми цепями
JP2008513405A5 (enExample)
CA2553513A1 (en) N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
TW201242955A (en) Nitrogen-containing heterocyclic compound
TW200424197A (en) Azole compounds
EA019742B1 (ru) Карбаматные производные алкилгетероциклов, их получение и их применение в терапии
KR101851418B1 (ko) 피리다지논 화합물 및 그 중간체의 제조 방법
US20040224946A1 (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
JP2012503005A5 (enExample)
KR20010020267A (ko) 신규한 디하이드로피리딘 유도체
JP2008520642A5 (enExample)
US9617240B2 (en) Pyrazole derivative